Jenoptik has more than doubled over the past year, and that kind of move naturally raises a blunt question for you as a shareholder or potential buyer. Is the current price near €39.88 still in line with the cash the business is expected to generate over time, or has the share chart run ahead of those cash flows?
-
The stock is up 104.1% over the past 12 months, which puts a lot of weight on the idea that future cash generation will justify such a rapid re-rating.
-
The business model relies heavily on turning revenue into dependable free cash flow, so assumptions around margins, reinvestment needs and working capital will matter more than short term price swings.
-
What if you looked at Jenoptik through its earnings instead? See why Jenoptik's 26.3x P/E tells a different valuation story .
The issue now is whether Jenoptik's current market value is adequately supported by its cash flows when viewed through a Discounted Cash Flow (DCF) lens.
If you want to test the same cash flow question you are asking of Jenoptik against a wider field, scan through 195 high quality undervalued stocks .
Does Jenoptik Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) approach looks at the cash Jenoptik could return to shareholders over time and discounts it back to today. On this model, the group is coming from a base of about €113.6 million in free cash flow over the last twelve months, with analyst projections pointing to higher annual cash generation by 2030.
What really matters for you is how those future cash flows compare with the current share price of €39.88. The DCF projections, which build in gradually rising free cash flow over the next decade, put Jenoptik's estimated intrinsic value meaningfully above the current share price. That gap is what the full valuation output is designed to quantify in more detail. Find out what Jenoptik could be worth using our Discounted Cash Flow (DCF) estimate .
The Jenoptik Narrative: What Would Justify Today's Price?
Narratives for Jenoptik pick up where the DCF question leaves off and spell out which specific paths for growth, profitability and earnings would need to play out for the share price to look meaningfully higher or lower than it does today. Each scenario links its valuation number to a clear view on how Jenoptik's growth, margins and key risks might evolve. This gives you a framework you can revisit as fresh information emerges.
One of the top community narratives on Jenoptik: 21% undervalued
"Ongoing portfolio shift towards higher-margin, software-enabled photonic solutions, combined with disciplined cost and cash management, is likely to support margin expansion…"
Discover why this Narrative puts Jenoptik at 21% undervalued .
Jenoptik's share price is only one piece of the decision
Before treating any valuation result as the whole story, it helps to weigh it against the specific concerns our checks have picked up on Jenoptik. Take a closer look at 1 warning sign before settling on a valuation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include JEN.DE .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
